We are live on ! Find out more
BCP

BlackBarn Capital Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 55.98%
This Fund
S&P 500
This Quarter Est. Return
+17.08%
1 Year Est. Return
+55.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.4B
AUM Growth
-$351M
Cap. Flow
-$460M
Cap. Flow %
-32.92%
Top 10 Hldgs %
90.52%
Holding
28
New
5
Increased
6
Reduced
7
Closed
8

Top Sells

Rank Stock Value
1
ACLS icon
Axcelis
ACLS
+$12.9M
2
INTC icon
Intel
INTC
+$12.3M
3
AMRX icon
Amneal Pharmaceuticals
AMRX
+$11.3M
4
EGBN icon
Eagle Bancorp
EGBN
+$10.4M
5
BRBS icon
Blue Ridge Bankshares
BRBS
+$8.5M

Sector Composition

Rank Sector Weight
1 Healthcare 12.61%
2 Technology 3.25%
3 Utilities 1.46%
4 Communication Services 1.03%
5 Financials 0.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$779B
$833M 59.6%
1,250,000
RMD icon
2
PUT
ResMed
RMD
$29.3B
$192M 13.71%
+700,000
New +$191M
ROIV icon
3
Roivant Sciences
ROIV
$25B
$66.6M 4.77%
4,400,000
-225,000
-5% -$2.79M
WRBY icon
4
PUT
Warby Parker
WRBY
$3.06B
$27.6M 1.97%
+1,000,000
New +$25.3M
PRVA icon
5
Privia Health
PRVA
$3.17B
$27.2M 1.94%
1,090,382
+340,382
+45% +$7.33M
DHC
6
Diversified Healthcare Trust
DHC
$2.25B
$27.1M 1.94%
6,150,000
-100,000
-2% -$381K
NXT icon
7
Nextpower Inc
NXT
$15.3B
$25.9M 1.85%
350,000
+40,000
+13% +$2.58M
OSCR icon
8
PUT
Oscar Health
OSCR
$8.72B
$23.7M 1.69%
+1,250,000
New +$20.6M
AMRX icon
9
Amneal Pharmaceuticals
AMRX
$5.73B
$21.9M 1.57%
2,189,452
-1,257,118
-36% -$11.3M
NEE icon
10
NextEra Energy
NEE
$185B
$20.4M 1.46%
270,000
+20,000
+8% +$1.46M
TEVA icon
11
Teva Pharmaceuticals
TEVA
$36.2B
$20.2M 1.45%
1,000,000
-50,000
-5% -$878K
ACLS icon
12
Axcelis
ACLS
$3.83B
$19.5M 1.4%
200,000
-160,000
-44% -$12.9M
MOH icon
13
Molina Healthcare
MOH
$10.6B
$18.2M 1.3%
95,000
+20,000
+27% +$3.68M
ELAN icon
14
PUT
Elanco Animal Health
ELAN
$12.6B
$15.1M 1.08%
+750,000
New +$12.6M
CCOI icon
15
Cogent Communications
CCOI
$601M
$14.4M 1.03%
375,000
+135,000
+56% +$5.64M
VKTX icon
16
Viking Therapeutics
VKTX
$4.11B
$13.1M 0.94%
500,000
+150,000
+43% +$4.47M
MH
17
McGraw Hill
MH
$2B
$10.7M 0.76%
+850,757
New +$12.3M
ABUS icon
18
Arbutus Biopharma
ABUS
$873M
$9.08M 0.65%
2,000,000
-603,521
-23% -$2.22M
FBLA
19
FB Bancorp
FBLA
$254M
$7.51M 0.54%
624,700
BVFL icon
20
BV Financial
BVFL
$185M
$4.7M 0.34%
291,442
-188,558
-39% -$3.05M
ARKK icon
21
PUT
ARK Innovation ETF
ARKK
$5.71B
-1,000,000
Closed -$70.3M
BRBS icon
22
Blue Ridge Bankshares
BRBS
$311M
-2,368,234
Closed -$8.5M
EGBN icon
23
Eagle Bancorp
EGBN
$860M
-532,181
Closed -$10.4M
HBNC icon
24
Horizon Bancorp
HBNC
$1.04B
-300,000
Closed -$4.61M
INTC icon
25
Intel
INTC
$453B
-550,000
Closed -$12.3M

Similar funds

BlackBarn Capital Partners's Q3 2025 Portfolio in Review

As of Q3 2025, BlackBarn Capital Partners held 28 positions worth $1.4B, down 20% from $1.75B the previous quarter. Its ten largest holdings account for 91% of the portfolio.

BlackBarn Capital Partners withdrew a net $460M in Q3 2025, closing 8 positions and reducing 7 holdings. Its most notable exit was Intel, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 8.9% a quarter earlier, followed by Technology and Utilities.

Against the trend, BlackBarn Capital Partners opened a new position in McGraw Hill worth $10.7M.

  • BlackBarn Capital Partners's largest Q3 2025 buy was McGraw Hill: 850,757 shares worth $10.7M.
  • BlackBarn Capital Partners added most to Privia Health in Q3 2025, an estimated $7.33M increase.
  • BlackBarn Capital Partners's biggest Q3 2025 reduction was Axcelis, cutting an estimated $12.9M.
  • BlackBarn Capital Partners fully exited Intel in Q3 2025, selling an estimated $12.3M.
  • BlackBarn Capital Partners's ten largest holdings make up 91% of its $1.4B portfolio in Q3 2025.
  • BlackBarn Capital Partners opened 5 new positions and closed 8 in Q3 2025.
  • BlackBarn Capital Partners's portfolio value fell 20% quarter-over-quarter to $1.4B.

Based on BlackBarn Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.